NCT05803434: Cannabidiol in Children and Young Adults With Rare Disease-associated Severe Epilepsy
- State
- Under way
- Phase
- Phase 2
- People
- 30 planned
- Started
- 14 Mar 2024
- Primary completion
- 1 Apr 2026
- Arms
- Cannabidiol treatment
- Results
- None posted
- 7 Apr 2023: Trial registered
- 14 Mar 2024: Trial started